Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Bolivian Mucosal Leishmaniasis With Miltefosine, Pentavalent Antimony or Liposomal Amphotericin B

NCT04799236 is registered in ClinicalTrials.gov with Fundacion Nacional de Dermatologia as lead sponsor.

NCT NCT04799236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Bolivian Mucosal Leishmaniasis With Miltefosine, Pentavalent Antimony or Liposomal Amphotericin B
Lead sponsor
Fundacion Nacional de Dermatologia
Phase
Phase 3
Overall status
Unknown status
Start date
April 1, 2021
Completion date
November 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucosal leishmaniasis